Targeting Gliomas

Stavroula Kyrkou; Vassilios Bistas; Andreas Tzakos

Previous Article in event

Pulmonary tuberculosis: A comorbidity or misdiagnosis of primary lung cancer in Africa?

Previous Article in session

Sanguinarine impedes Human Oral Cancer via attenuating Reactive Oxygen Species and PI3K/Akt/MAP kinase pathway

Next Article in event

Cancer Immunotherapy three ways

Targeting Gliomas

Stavroula Kyrkou

Vassilios Bistas

Andreas G Tzakos

¹ Department of Chemistry, University of Ioannina, Ioannina, Greece

Academic Editor: Vasso Apostolopoulos

Published: 02 April 2024 by MDPI in The 4th International Electronic Conference on Cancers session Cancer Immunology and Immunotherapy

Abstract:

The prognosis for patients with GBM remains poor and novel therapeutic approaches to address this unmet clinical need are urgently required. In this work we will present our recent efforts to develop compounds to target and tackle gliomas. Furthermore, we will illustrate other approaches that we are following to develop novel theranostic compounds that could be able to target the specific tumor microenvironment.

Keywords: prognosis; gilomas; GBM; thernostic compounds; tumour microenvironment

0 Reads
0 Recommendations

Stavroula Kyrkou

Vassilios Bistas

Andreas Tzakos